25 companies

uniQure

Market Cap: US$3.1b

Develops treatments for patients suffering from rare and other devastating diseases in the United States.

New

QURE

US$44.06

7D

20.2%

1Y

214.7%

Bausch Health Companies

Market Cap: US$2.6b

Operates as a diversified specialty pharmaceutical and medical device company.

New

BHC

US$7.00

7D

54.9%

1Y

17.8%

CareDx

Market Cap: US$2.5b

Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.

New

CDNA

US$47.85

7D

33.8%

1Y

272.4%

Replimune Group

Market Cap: US$1.0b

A clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer in the United States and the United Kingdom.

New

REPL

US$11.91

7D

122.6%

1Y

88.4%

GlaxoSmithKlineE

Market Cap: ج.م28.8b

Engages in production of pharmaceutical chemicals.

New

BIOC

ج.م345.25

7D

107.4%

1Y

623.8%

Egyptian International Pharmaceutical Industries

Market Cap: ج.م25.3b

Manufactures and sells pharmaceutical ampoules in Egypt and internationally.

New

PHAR

ج.م149.76

7D

60.3%

1Y

192.2%

iX Biopharma

Market Cap: S$588.2m

A specialty pharmaceutical and nutraceutical company, develops, manufactures, and commercializes therapies for the treatment of acute and breakthrough pain, and other health conditions in Singapore, the United States, China, and Australia.

New

42C

S$0.54

7D

27.1%

1Y

2,742.1%

Anika Therapeutics

Market Cap: US$241.8m

A joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally.

New

ANIK

US$19.28

7D

29.0%

1Y

123.1%

Thor Medical

Market Cap: NOK 2.0b

Produces and supplies alpha-particle emitters for cancer therapy in Norway.

New

TRMED

NOK 5.66

7D

26.3%

1Y

129.1%

Entera Bio

Market Cap: US$145.4m

A clinical stage company, engages in the development of oral peptides and protein replacement therapies in Israel and internationally.

New

ENTX

US$2.99

7D

45.9%

1Y

53.3%

Nyrada

Market Cap: AU$169.1m

A pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular and neurological diseases.

New

NYR

AU$0.69

7D

24.5%

1Y

114.1%

Eloxx Pharmaceuticals

Market Cap: US$74.5m

A clinical-stage biopharmaceutical company, develops small-molecule product candidates that modulate the ribosome and promote readthrough of premature stop codons caused by nonsense mutations in the United States, Israel, and Australia.

New

ELOX

US$18.45

7D

44.0%

1Y

1,678,698.9%

Medico Remedies

Market Cap: ₹4.1b

Develops, manufactures, and sells pharmaceutical and nutraceutical products in India.

New

540937

₹50.00

7D

23.0%

1Y

25.1%

BetterLife Pharma

Market Cap: US$39.7m

A biotechnology company, engages in the development of psychedelic-derived compounds.

New

BETR.F

US$0.24

7D

48.5%

1Y

274.0%

Sabaa International Company for Pharmaceutical and Chemical Industry

Market Cap: ج.م1.3b

Operates as a healthcare company in Egypt.

New

SIPC

ج.م5.00

7D

24.7%

1Y

55.8%

Devonian Health Group

Market Cap: CA$28.2m

Operates as a clinical stage biopharmaceutical corporation with novel therapeutic approaches targeting unmet medical needs in Canada and Internationally.

New

GSD

CA$10.14

7D

35.2%

1Y

12.7%

Medicure

Market Cap: CA$12.3m

A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.

New

MPH

CA$1.30

7D

25.0%

1Y

17.1%

Blueberries Medical

Market Cap: CA$9.9m

A consumer science company, engages in the commercialization of medicinal cannabis and related products in Colombia.

New

BBM

CA$0.02

7D

33.3%

1Y

100.0%

Panacea Life Sciences Holdings

Market Cap: US$5.5m

Operates as a holding company, researchers, develops, manufactures, produces, and distributes cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products for humans and animals.

New

PLSH

US$0.092

7D

23.2%

1Y

185.1%

Cannabis Global

Market Cap: US$789.6k

Focuses on the creating and commercialization of engineered technologies to deliver hemp extracts and cannabinoids to the human body.

New

CBGL

US$0.0001

7D

100.0%

1Y

0%

Rimrock Gold

Market Cap: US$576.8k

Through its subsidiary, focuses on the development and marketing a line of CBD oils, creams, and hemp extracts.

New

RMRK

US$0.0003

7D

20.0%

1Y

0%

Endonovo Therapeutics

Market Cap: US$180.8k

A biotechnology company, engages in the development, manufacture, and distribution of non-invasive Electroceutical medical devices for regenerative medicine.

New

ENDV

US$0.0001

7D

9,900.0%

1Y

0%

Affymax

Market Cap: US$111.7k

Does not have significant operations.

New

AFFY

US$0.0015

7D

50.0%

1Y

87.5%

PaxMedica

Market Cap: US$63.1k

A clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms.

New

PXMD

US$0.0007

7D

40.0%

1Y

600.0%

MPX International

Market Cap: US$14.4k

Operates as a cannabis company in Canada and internationally.

New

MPXO.F

US$0.0001

7D

9,900.0%

1Y

9,900.0%